We are live on ! Find out more
PC

Paulson & Co Portfolio holdings

AUM $3.11B
1-Year Est. Return 94.93%
This Fund
S&P 500
This Quarter Est. Return
+3.07%
1 Year Est. Return
+94.93%
3 Year Est. Return
+233.32%
5 Year Est. Return
+258.51%
10 Year Est. Return
+934.97%
AUM
$16.7B
AUM Growth
-$2.54B
Cap. Flow
-$2.62B
Cap. Flow %
-15.66%
Top 10 Hldgs %
66.45%
Holding
90
New
25
Increased
9
Reduced
23
Closed
13

Top Buys

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$492M
2
LRCX icon
Lam Research
LRCX
+$376M
3
LIVN icon
LivaNova
LIVN
+$216M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$149M
5
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$137M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$491M
2
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$418M
3
GLD icon
SPDR Gold Trust
GLD
+$366M
4
HCA icon
HCA Healthcare
HCA
+$365M
5
HOT
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
+$285M

Sector Composition

Rank Sector Weight
1 Healthcare 54.51%
2 Communication Services 12.17%
3 Real Estate 6.6%
4 Consumer Discretionary 5.63%
5 Financials 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
51
Vertex Pharmaceuticals
VRTX
$124B
$5.84M 0.03%
+46,400
New +$5.6M
IAG icon
52
IAMGOLD
IAG
$8.03B
$5.49M 0.03%
3,863,912
– –
THM
53
International Tower Hill Mines
THM
$487M
$4.5M 0.03%
23,058,000
– –
GMED icon
54
Globus Medical
GMED
$10.9B
$3.68M 0.02%
+132,300
New +$3.32M
ETSY icon
55
Etsy
ETSY
$8.13B
$3.61M 0.02%
+437,010
New +$4.43M
PBYI icon
56
Puma Biotechnology
PBYI
$399M
$3.61M 0.02%
+46,000
New +$3.61M
TMQ
57
Trilogy Metals
TMQ
$504M
$3.35M 0.02%
11,835,319
– –
DVAX
58
DELISTED
Dynavax Technologies
DVAX
$3.23M 0.02%
+133,800
New +$3.35M
KMDA icon
59
Kamada
KMDA
$406M
$3.06M 0.02%
739,356
– –
INSM icon
60
Insmed
INSM
$22.6B
$3M 0.02%
+165,200
New +$2.91M
LH icon
61
Labcorp
LH
$25.4B
$2.92M 0.02%
+27,470
New +$2.83M
BAC.WS.B
62
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$2.43M 0.01%
8,986,800
-275,000
-3% -$87.7K
LOXO
63
DELISTED
Loxo Oncology, Inc
LOXO
$2.34M 0.01%
+82,179
New +$2.21M
NUVA
64
DELISTED
NuVasive, Inc.
NUVA
$1.72M 0.01%
+31,800
New +$1.62M
RIGL icon
65
Rigel Pharmaceuticals
RIGL
$713M
$1.6M 0.01%
+52,870
New +$1.6M
MCK icon
66
McKesson
MCK
$105B
$1.6M 0.01%
+8,100
New +$1.53M
ALNY icon
67
Alnylam Pharmaceuticals
ALNY
$38.2B
$1.16M 0.01%
+12,300
New +$1.14M
BKNG icon
68
Booking.com
BKNG
$157B
$1.15M 0.01%
+22,500
New +$1.19M
ESPR
69
DELISTED
Esperion Therapeutics
ESPR
$501K ﹤0.01%
+22,500
New +$568K
MNTA
70
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$324K ﹤0.01%
+21,800
New +$365K
AEGR
71
DELISTED
Aegerion Pharmaceuticals
AEGR
$267K ﹤0.01%
+26,400
New +$318K
DXM
72
DELISTED
DEX MEDIA INC NEW COM STK (DE)
DXM
$267K ﹤0.01%
1,347,437
-883,695
-40% -$152K
SU icon
73
Suncor Energy
SU
$77.5B
$3K ﹤0.01%
+100
New +$2.76K
HCA icon
74
HCA Healthcare
HCA
$91.7B
– –
-4,711,900
Closed -$365M
HHH icon
75
Howard Hughes
HHH
$4B
– –
-173,085
Closed -$18.9M
1 2
3
4

Similar funds

TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
EAM
EULAV Asset Management Sarasota, Florida $3.12B AUM 13.38% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
DCM
Donaldson Capital Management Evansville, Indiana $3.09B AUM 21.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Paulson & Co's Q4 2015 Portfolio in Review

As of Q4 2015, Paulson & Co held 90 positions worth $16.7B, down 13% from $19.3B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Paulson & Co withdrew a net $2.62B in Q4 2015, closing 13 positions and reducing 23 holdings. Its most notable exit was HCA Healthcare, an estimated $365M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 46% a quarter earlier, followed by Communication Services and Real Estate.

Against the trend, Paulson & Co opened a new position in Lam Research worth $397M.

  • Paulson & Co's largest Q4 2015 buy was Lam Research: 50,000,000 shares worth $397M.
  • Paulson & Co added most to Bausch Health in Q4 2015, an estimated $492M increase.
  • Paulson & Co's biggest Q4 2015 reduction was Allergan plc, cutting an estimated $491M.
  • Paulson & Co fully exited HCA Healthcare in Q4 2015, selling an estimated $365M.
  • Paulson & Co's ten largest holdings make up 66% of its $16.7B portfolio in Q4 2015.
  • Paulson & Co opened 25 new positions and closed 13 in Q4 2015.
  • Paulson & Co's portfolio value fell 13% quarter-over-quarter to $16.7B.

Based on Paulson & Co's 13F filing for Q4 2015, filed 16 Feb 2016.